A systematic review and meta-analysis of family history and risk of ovarian cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 5, 1998, Pages 493-499

  Stratton, John F ^a   Pharoah, Paul ^b   Smith, Steven K ^c   Easton, Doug ^b   Ponder, Bruce A J ^a,d  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Rosie Maternity Hospital   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; META ANALYSIS; OVARY CANCER; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FAMILY HEALTH; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; RISK ASSESSMENT; RISK FACTORS;

EID: 0031812042     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10148.x     Document Type: Article

References (28)

1. Miki Y, Swensen J, Shattuck, Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.
2. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature; 1995; 37: 789–792.
3. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1 & 2. Lyon: IARC, 1987.
4. Houlston R, Bourne TH, Davies A et al. Use of family history in a screening clinic for familial ovarian cancer. Gynecol Oncol 1992; 47: 247–252.
5. Schildkraut JM, Thompson WD. Familial overian cancer: a population based case, control study. Am J Epidemiol 1998; 128: 456–466.
6. Easton D, Matthew F, Ford D, Swerdlow A, Peto J. Cancer mortality in relatives of women with overian cancer: the OPCS study. Int J Cancer 1996; 65: 284–294.
7. Kerlikowske K, Brown JS, Grady DG. Should women with familial overian cancer undergo prophylactic oophorectomy Obstet Gynecol 1992; 80: 419–424.
8. Whittemore A, Harris R, Itnyre J. The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US Case-Control Studies, 2. Invasive epithelial cancers in white women. Am J Epidemiol 1992; 136: 1184–1203.
9. Goldgar D, Easton DF, Cannon-Albright L, Skolnick MH. Systematic population-based assessment of cancer risk in first degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600–1607.
10. Hartge P, Whittemore A, Itnyre J, McGowan L, Cramer D. The Collaborative Ovarian Cancer Group. Rates and risks of ovarian cancer in subgroups of white women in the United States. Obstet Gynecol 1994; 84: 760–764.
11. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk: I. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711–716.
12. Purdie D, Green A, Bain C et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995; 62: 678–684.
13. Parazzini F, Negri E, La Vecchia C, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case, control study. Am J Epidemiol 1992; 135: 35–40.
14. Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S, Salmi T. Cancer incidence in the first degree relatives of ovarian cancer patients. Br J Cancer 1996; 74: 280–284.
15. Clayton D, Hills M. Statistical Methods in Epidemiology. Oxford: Oxford University Press, 1993.
16. Schildkraut JM. Risch N, Thompson WD. Evaluating genetic association among ovarian, breast and endometrial cancer: evidence for a breastiovarian cancer relationship. Am J Hum Genet 1989; 45: 521–529.
17. Kerber RA, Slattery ML. The impact of family history on ovarian cancer risk. The Utah Population Database Arch Intern Med 1995; 155: 905–912.
18. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. Incessant ovulation and ovarian cancer. Lancet 1979; 2: 170–173.
19. Koch M, Gaedke H, Jenkins H. Family history of ovarian cancer patients: a case-control study. Int J Epidemiol 1989; 18: 782–785.
20. Stratton JF, Gayther SA, Russell P et al. The contribution of mutations in BRCA1 to ovarian cancer. N Engl. J Med 1997; 336: 1125–1130.
21. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457–1462.
22. Gayther SA, Mangion J, Russell, P et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of and BRCA2 gene. Nat Genet 1997; 15: 103–105.
23. Booth M. Aspects of the epidemiology of ovarian cancer [PhD thesis]. London: University of London; 1986.
24. Hildreth NG, Kelsey JL, LiVolsi VA et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114: 398–405.
25. Mori M, Harabuchi I, Miyake H, Casagrande JT, Henderson BE, Ross RK. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 1988; 128: 771–777.
26. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989; 161: 10–16.
27. Rosenberg L, Palmer JR, Zauber AG et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994; 139: 654–661.
28. Tzonou A, Day N, Trichopoulos D et al. The epidemiology of ovarian cancer in Greece: a case, control study. Eur J Cancer Clin Oncol 1984; 20: 1045–1052.